Thomas Francis DO Mendolia

Thomas Francis DO Mendolia discloses dealings in 2 companies, chiefly Medytox Solutions, Inc. and Rennova Health, Inc. Between 13 March 2014 and 21 September 2016, the trades on record add up to 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 22 September 2016: a transaction, in Rennova Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 9 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.